Fudan University: Biliary Tract Neoplasms trials
The registry lists 12 Biliary Tract Neoplasms studies with Fudan University as lead sponsor. 6 are open to participants now and 0 have results posted.
Phase 1 1Phase 2 8Phase 3 1No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Cryoablation Combined With QL1706 (Iparomlimab/Tuvonralimab) Plus Lenvatinib in Patients With Advanced Biliary Tract Cancer.Not yet recruitingNCT07829874Phase 2
- Yueju Pill Combined With Standard Therapy In Advanced Biliary Tract CancerNot yet recruitingNCT07169916Not applicable
- GemCis Plus PD-1/PD-L1 Inhibitor in Advanced Biliary Tract Cancer: Efficacy and Immune Microenvironment （BTC-IM-1）RecruitingNCT06988592
- Oncolytic Virus H101 Combined With Lenvatinib Plus Toripalimab Compared With FOLFOX in Patients With Advanced Biliary Tract Cancer (OPTIONS-06)Not yet recruitingNCT06919848Phase 2
- Oncolytic Virotherapy Combined With Tislelizumab Plus Lenvatinib in Patients With Advanced Biliary Tract Cancer (OPTIONS-05)RecruitingNCT05823987Phase 2
- Cryoablation Combined With Sintilimab Plus Lenvatinib in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Biliary Tract Cancer （CASTLE-08）RecruitingNCT05781074Phase 2
- Capecitabine Combined With Lenvatinib and Tislelizumab as Adjuvant Treatment After Resection in Patients With BTCCompletedNCT05254847Phase 2
- Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab in Unresectable Biliary Tract CancerStatus unknownNCT04984980Phase 2
- GEMOX Combined With Donafenib and Tislelizumab in Biliary Tract CancerStatus unknownNCT04979663Phase 1/2
- A Study of Capecitabine Versus S-1 as Adjuvant Therapy in Patients With Biliary Tract Carcinoma After Surgical ResectionStatus unknownNCT04856761
- Apatinib for Advanced Biliary CarcinomaStatus unknownNCT03427242Phase 2
- Nonstented Stump-closed vs Duct-to-Mucosa Pancreaticojejunostomy After PancreaticoduodenectomyCompletedNCT01731821Phase 3